Actuate Therapeutics, Inc.
ACTU
$1.95
$0.021.04%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 3.14M | 2.56M | 3.29M | 3.20M | 3.15M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.71M | 4.69M | 5.47M | 5.97M | 6.37M |
| Operating Income | -5.71M | -4.69M | -5.47M | -5.97M | -6.37M |
| Income Before Tax | -5.63M | -4.55M | -5.41M | -5.95M | -6.32M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.63M | -4.55M | -5.41M | -5.95M | -6.32M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.63M | -4.55M | -5.41M | -5.95M | -6.32M |
| EBIT | -5.71M | -4.69M | -5.47M | -5.97M | -6.37M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.24 | -0.19 | -0.25 | -0.30 | -0.32 |
| Normalized Basic EPS | -0.15 | -0.12 | -0.16 | -0.19 | -0.20 |
| EPS Diluted | -0.24 | -0.19 | -0.25 | -0.30 | -0.32 |
| Normalized Diluted EPS | -0.15 | -0.12 | -0.16 | -0.19 | -0.20 |
| Average Basic Shares Outstanding | 23.54M | 23.53M | 21.40M | 19.65M | 19.50M |
| Average Diluted Shares Outstanding | 23.54M | 23.53M | 21.40M | 19.65M | 19.50M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |